We are live on
!
Find out more
AYLA
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA
Delisted
AYLA was delisted on the 18th of January, 2023.
7 hedge funds and large institutions have $19.4M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% more capital invested
Capital invested by funds: $18.8M → $19.4M (+$638K)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.17M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.5K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$13.3K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$177K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$52.9K |
| 3 |
SCM
Sio Capital Management
New York
|
-$38.2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.74K |